Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 28 | 30 | +2 |
| Shares | 330.1K | 442.5K | +112.4K (+34.0%) |
| Value | $617.7K | $260.3K | −$357.4K (−57.9%) |
New holders (8)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 65,734 | $38.5K | 0.00% |
| DRW Securities, LLC | 46,374 | $27.2K | 0.00% |
| Susquehanna International Group, LLP | 21,113 | $12.4K | 0.00% |
| XTX Topco Ltd | 16,909 | $9.91K | 0.00% |
| Jane Street Group, LLC | 15,899 | $9.32K | 0.00% |
| Virtu Financial LLC | 15,569 | $9.00K | 0.00% |
| SageView Advisory Group, LLC | 10 | $6 | 0.00% |
| Motiv8 Investments LLC | 4 | $0 | 0.00% |
Sold out (6)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Northern Trust Corp | 22,594 | $42.7K |
| Two Sigma Securities, LLC | 12,560 | $23.7K |
| HRT Financial LP | 10,784 | $20.0K |
| Citigroup Inc | 1,260 | $2.38K |
| Rockefeller Capital Management L.P. | 500 | $945 |
| FMR LLC | 5 | $9 |